Read Time 21 minutes

Heart Age and Cardiovascular Health: How to Stay Younger, Longer

Key takeaways 

  • Heart age reveals your cardiovascular risk by showing how old your heart is compared to your actual age.
  • An older heart age signals higher but changeable risks for heart disease, stroke, and other cardiovascular issues.
  • Healthy lifestyle changes can lower your heart age, helping you protect your heart and bring it closer to your chronological age.

Overview 

Heart disease is still the leading cause of death worldwide, making it crucial to track your cardiovascular health. But standard checkups don’t always reveal the whole picture. 

That’s where heart age comes in, a simple yet powerful way to estimate how old your heart is based on your lifestyle and health factors. 

Heart age calculators use key risk indicators like blood pressure, BMI, smoking habits, and even socioeconomic status to predict your risk of heart attack or stroke.

In this blog, you’ll learn what heart age means, how it’s calculated, why it matters, and whether lifestyle changes or supplements can help you improve it. 

Understanding your heart’s age provides a personalized snapshot of your cardiovascular health and an opportunity to take control before potential problems arise.

What is heart age? 

Heart age estimates how “old” your heart is in terms of cardiovascular health compared to a healthy individual of your chronological age. The concept evaluates key risk factors such as blood pressure, cholesterol, smoking habits, diabetes status, and BMI. Maintaining a healthy weight is essential, and body mass index (BMI) is commonly used in these assessments to help determine if you are within a healthy weight range. 

For example, if you’re a 40-year-old with elevated blood pressure or smoking habits, your heart age might be assessed at 50. This higher number indicates a higher risk of heart attack, stroke, or other cardiovascular conditions, especially if you or your family have a history of being diagnosed with heart attack or stroke. Ideally, your heart age should be the same as, or younger than, your actual age, reflecting better cardiovascular health. 

Historical context 

The concept of heart age became popularized as a communication tool to simplify complex cardiovascular metrics. Government health organizations in countries such as the U.S. (CDC), the UK (NHS), and China have incorporated heart age calculators into public health campaigns. The aim is to better engage individuals in managing their cardiovascular risk factors by providing a clear and easy-to-understand estimate of their risk. Family history and personal history of cardiovascular events, such as heart attack or stroke, are important factors considered in heart age calculators. 

However, while millions globally have used heart age calculators, studies reveal their limitations. They are best suited as motivational tools for lifestyle changes rather than standalone predictors for medical interventions.

How does heart age affect your cardiovascular health?

Your heart age offers a powerful window into your cardiovascular health, often revealing risks that standard tests might miss. When your heart age is higher than your actual age, it signals that your heart and blood vessels may be aging faster, raising your chances of heart disease, stroke, and other serious health issues. Here’s what you need to understand to prevent the potential risks: 

Elevated heart age and risk of heart diseases 

A heart age older than your chronological age typically suggests elevated but modifiable risk factors for cardiovascular events like heart attacks or strokes. Understanding this metric can guide you toward health-improving steps that may reduce your risk. 

For instance, one large-scale study by the CDC revealed that 43.7% of individuals aged 30–74 had a heart age at least five years older than their actual age. Such data highlights widespread unmet needs in preventive care. 

Limitations and pitfalls 

While heart age calculators provide emotional resonance and educational value, they may lead to misunderstandings about cardiovascular risk. Research has shown that they sometimes overemphasize age-related risks without accounting for absolute risk thresholds for medical interventions. 

Some calculators do not account for conditions such as peripheral artery disease or heart failure, which can impact the accuracy of the assessment and potentially lead to an overestimation of heart age or cardiovascular risk.

For example: 

  • Someone with a “high heart age” may have a low absolute risk of a cardiovascular event in the next 5–10 years, leading to unnecessary anxiety. 
  • Additionally, heart age is often less reliable for younger individuals or those with mild risk factors. 

When to track heart age and why it matters? 

The utility of heart age lies in its ability to motivate individuals toward proactive health management. Tracking heart age can be particularly useful for: 

  1. Identifying modifiable risk factors (e.g., high cholesterol or smoking). 
  2. Encouraging early lifestyle changes in individuals with borderline health metrics. 
  3. Providing insights for future check-ins with healthcare providers, who can support patients with information and resources and help manage heart health based on heart age assessments.

Key areas to improve heart age

Improving your heart age starts with everyday choices that directly impact cardiovascular health. Diet, exercise, and carefully selected supplements can all help lower heart age and reduce the risk of heart disease when applied consistently and under proper guidance.

Diet and lifestyle 

Eating a heart-healthy diet is critical to reducing cardiovascular risk. The Mediterranean diet, rich in omega-3 fatty acids, fruits, vegetables, and whole grains, consistently demonstrates cardioprotective benefits. 

Regular physical activity also plays a crucial role. Current guidelines recommend at least 150 minutes of moderate-intensity exercise per week for adults. Activities such as brisk walking, swimming, or cycling improve circulation, lower blood pressure, and enhance overall cardiovascular health and resilience. 

Additionally, avoid high-sodium and processed foods, as they increase your risk of hypertension, a key contributor to an older heart age. 

The role of supplements 

Supplements may complement lifestyle efforts in improving heart health, but it is essential to consult with a medical or healthcare professional before starting any supplements. Two notable examples include: 

  1. Nicotinamide mononucleotide (NMN) 

NMN increases arterial SIRT1 activity, reversing age-related arterial dysfunction and reducing oxidative stress. Studies on older mice showed improved endothelial function, normalized arterial stiffness, and reduced oxidative damage after NMN supplementation. 

  1. Resveratrol 

Commonly found in red wine and grape extracts, resveratrol has been shown to offer potential cardiovascular benefits. It enhances mitochondrial function, reduces oxidative stress, and improves insulin sensitivity. Specific studies revealed its role in lowering LDL cholesterol and improving arterial flexibility. 

Important considerations 

Always consult a healthcare provider before starting supplements, as their efficacy and safety can vary depending on individual health conditions and other factors. 

Emotional Well-being

Chronic stress has a significant impact on cardiovascular health, often leading to elevated blood pressure and increased heart rate. Chronic stress can also contribute to heart problems and increase the risk of developing a heart condition. Mindfulness techniques, such as yoga and meditation, show promising results in reducing heart rate variability and stress markers. 

Sleep is another critical factor. Poor sleep hygiene is associated with higher blood pressure and other adverse health outcomes. To improve heart health, aim for 7–8 hours of quality sleep per night. 

Frequently asked questions (FAQs)

  1. Can my heart age be reversed? 

Yes, to an extent. While age-related cellular changes are inevitable, lifestyle adjustments, improved dietary habits, and regular exercise can significantly reduce modifiable risk factors and better align your heart age with your actual age. 

  1. What is the difference between heart age and absolute risk? 

Heart age is a simplified metric indicating general cardiovascular health and risk factors. Absolute risk quantifies the precise probability of experiencing a cardiovascular event within a specific timeframe (e.g., the next 5–10 years). Absolute risk may be more reliable for clinical decision-making. 

  1. How often should I track my heart age? 

Review it annually or during regular check-ups. However, significant changes in lifestyle, weight, or health status may warrant more frequent monitoring.

References 

  1. Bonner, Carissa, et al. “Should Heart Age Calculators Be Used alongside Absolute Cardiovascular Disease Risk Assessment?” BMC Cardiovascular Disorders, vol. 18, no. 1, Dec. 2018, p. 19. 
  2. Houston, Mark, et al. “Recent Science and Clinical Application of Nutrition to Coronary Heart Disease.” Journal of the American College of Nutrition, vol. 37, no. 3, Apr. 2018, pp. 169–87.  
  3. Linton, Phyllis-Jean, et al. “This Old Heart: Cardiac Aging and Autophagy.” Journal of Molecular and Cellular Cardiology, vol. 83, June 2015, pp. 44–54. 
  4. Novelle, Marta G., et al. “Resveratrol Supplementation: Where Are We Now and Where Should We Go?” Ageing Research Reviews, vol. 21, May 2015, pp. 1–15.  
  5. Picciotto, Natalie E., et al. “Nicotinamide Mononucleotide Supplementation Reverses Vascular Dysfunction and Oxidative Stress with Aging in Mice.” Aging Cell, vol. 15, no. 3, June 2016, pp. 522–30. 

Share
4 subscribe
Subscribe

RELATED CONTENT

Platelets the overlooked cognitive factors revolutionizing brain health research
Brain Age Test: What Stanford’s Young Brain Study Says About Your Lifespan
More
How to age gracefully tips and supplements for vitality
How to Age Gracefully: Tips and Supplements for Vitality 
More
Dose coffee age you what science says about your daily brew
Does Coffee Age You? What Science Really Says About Your Daily Brew
More
How old is old exploring the perspectives on aging and subjective definitions of old age
How Old Is Old? Exploring the Perspectives on Aging and Subjective Definitions of Old Age
More

Longevity, Delivered to Your Inbox

Subscribe for curated research updates, practical tips, and the latest anti-aging breakthroughs

Subscription Form

Colton

Colton Qiu, PhD

Editor-in-Chief, Scientific Research

Colton is a regenerative medicine scientist with a focus on transfusion science, stem cell engineering, and platelet-based therapies. He earned his PhD in Medicine from Kyoto University’s Center for iPS Cell Research and Application (CiRA), the pioneering institute behind induced pluripotent stem cell (iPSC) technology. His research centered on improving the biomanufacturing process and long-term preservation of iPSC-derived platelets, advancing their applications in both transfusion medicine and next-generation PRP (platelet-rich plasma) therapies for tissue regeneration.

Beyond the lab, Colton is the co-founder and former president of the Japan–Taiwan Biotechnology Association (JTBA), where he played a pivotal role in establishing high-impact collaborations between academia, industry, and government to foster regenerative medicine innovation across Asia. He completed his doctoral training with the support of the Japan–Taiwan Exchange Association Scholarship, awarded for his outstanding contributions to cross-cultural scientific advancement.

Since completing his PhD, Colton has turned his focus toward the future of personalized healthcare. He firmly believes that science-backed strategies to delay aging and enhance healthspan already exist—but they must be tailored to each individual. Rejecting the idea of a “one-size-fits-all” solution, he advocates for making personalized longevity planning both scientifically rigorous and economically accessible. His mission is to help more people design evidence-based, customized pathways to healthier, longer lives.

Right down 2
Tristan

Tristan Yeung, MD

Editor-in-Chief, Medical Research

Tristan brings a distinctive perspective to longevity research through his integration of clinical medicine, translational research, and biomedical innovation. His MD from Harvard Medical School, combined with extensive engagement with Harvard Innovation Lab and HMS Makerspace, reflects his commitment to transforming scientific discoveries into practical interventions that can extend healthy human lifespan. His internal medicine internship at California Pacific Medical Center provides him with frontline clinical experience in treating age-related diseases, giving him intimate knowledge of how aging manifests in real patients and what interventions might have the greatest impact on healthspan extension.

Tristan’s translational research at Stanford’s Department of Radiology and Canary Center, where he implemented novel microRNA-encapsulated nanoparticle drug delivery systems for localized cancer treatment, demonstrates his expertise in cutting-edge therapeutic delivery mechanisms increasingly relevant to anti-aging interventions. His bioengineering background from Stanford University, where he developed a vitamin-eluting subdermal implantable rod for nutritional deficiencies as a Terman Engineering Scholar, showcases his innovative approach to sustained therapeutic delivery – a critical consideration for longevity interventions that must work over extended timeframes. Tristan’s unique combination of clinical training, research expertise, and entrepreneurial vision enables him to identify which longevity interventions hold promise for extending not just lifespan, but healthspan.

Right down 2
Jean cruz

Jean Cruz-Hernandez, PhD

Scientific Advisor

Jean Cruz (JC) combines deep scientific rigor with strategic vision as Global Managing Partner of AGMI, bringing a rare blend of bench science expertise and commercial acumen to longevity research analysis. His PhD in Biomedical Engineering from Cornell University, coupled with a postdoctoral fellowship and junior faculty position at Massachusetts General Hospital and Harvard Medical School, provides him with the technical depth needed to evaluate complex longevity interventions with scientific precision. JC’s pioneering work in neurodegenerative diagnostic and imaging platforms during his academic career gives him unique insight into one of aging’s most devastating aspects – cognitive decline, while his research that produced several US patents, over $5 million in sponsored grants, and publications in Nature demonstrates his ability to identify breakthrough approaches that could revolutionize how we understand aging processes. His specialized research initiatives focused on understanding aging-related neurological decline and developing therapeutic interventions position him at the forefront of one of longevity science’s most critical frontiers.

His extensive experience at McKinsey & Company, where he led strategic transformations for Fortune 500 pharma companies and conducted due diligence across oncology, neuroscience, and rare-disease portfolios, equips him to navigate the complex landscape of longevity research with both scientific rigor and commercial insight. JC’s work positions him to identify which approaches have genuine therapeutic potential versus those destined for clinical failure. JC brings unparalleled expertise in translating cutting-edge aging research into practical strategies that can extend healthy human aging.

Right down 2
Harvey

Yen-Po (Harvey) Chin, MD, PhD

Medical Advisor and Strategy Lead

Harvey brings a unique convergence of clinical medicine, bioinformatics, and advanced analytics to the pursuit of longevity science, combining deep scientific training with strategic vision to advance anti-aging research. His medical training from National Yang Ming Chiao Tung University and his PhD in Biomedical Informatics from Taipei Medical University, coupled with his postdoctoral Master of Biomedical Informatics from Harvard Medical School, positions him uniquely at the intersection where cutting-edge longevity research meets computational analysis and practical implementation. As a physician turned entrepreneur, Harvey understands both the clinical realities of aging-related diseases and the technological possibilities for intervention, giving him rare insight into how breakthrough biomedical innovations can translate from laboratory discoveries to meaningful patient outcomes.

As a Forbes 30 Under 30 honoree and Harvard Healthtech Innovation Fellow, Harvey has consistently identified and championed emerging technologies before they reach mainstream adoption, a skill directly applicable to the rapidly evolving field of longevity research. His experience as Executive Chairman of AGMI Group, where he has orchestrated over $1.5 billion in potential value through strategic partnerships in biopharma and advanced technology enterprises, demonstrates his ability to discern which medical interventions hold genuine therapeutic promise versus those destined for clinical failure. His frequent speaking engagements at Harvard, MIT, BIO Asia Conference, and Academia Sinica position him to stay at the forefront of longevity research developments as they emerge from the world’s leading institutions, while his commitment to developing the next generation of leaders through the AAC Talent Hub reflects his dedication to ensuring breakthrough anti-aging discoveries benefit future generations.

Right down 2

Longevity, Delivered to Your Inbox

Subscribe for curated research updates, practical tips, and the latest anti-aging breakthroughs

Subscription Form